Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.200 | None | 0.947 | 6572 | 76 | 1987 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.100 | None | 0.969 | 2979 | 38 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.200 | None | 0.945 | 2944 | 20 | 1987 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.500 | None | 0.944 | 1796 | 14 | 1984 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 0.962 | 1783 | 0 | 2003 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.968 | 1758 | 12 | 1992 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.200 | None | 0.976 | 1552 | 15 | 1997 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.953 | 1446 | 13 | 1983 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.200 | None | 0.946 | 1386 | 14 | 2002 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.943 | 1380 | 16 | 1981 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.500 | None | 0.964 | 1116 | 19 | 1993 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.200 | None | 0.977 | 1052 | 8 | 1998 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.955 | 933 | 10 | 1994 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 0.948 | 886 | 4 | 1984 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.100 | None | 0.963 | 725 | 4 | 1999 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.921 | 675 | 0 | 1994 | 2020 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.990 | 669 | 2 | 1998 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 0.989 | 664 | 1 | 1998 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.989 | 662 | 4 | 1998 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.984 | 639 | 3 | 1999 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.500 | None | 0.967 | 629 | 1 | 1983 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.100 | None | 0.979 | 611 | 4 | 1998 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.978 | 590 | 4 | 1987 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 0.960 | 577 | 3 | 1985 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.100 | None | 0.933 | 555 | 17 | 1993 | 2020 |